AIM Biotech is a leading bioengineering company, offering scalable, cost-effective 3D cell culture platforms, drug screening services, and customized assay development. By combining model realism and platform simplicity, AIM’s plug-and-play technologies empower drug developers to mimic human biology with precision, delivering clinically-relevant data.

Our AKITA high-throughput microfluidic platform is compatible with standard laboratory equipment to supports a wide range of applications from compound screening to basic research. It elicits the modeling & monitoring of biological processes in healthy and diseased states.

Alcyomics is a pre-clinical service provider using Skimune®, non-artificial human skin explants to predict adverse immune reactions of novel compounds. The Skimune® platform also assess the efficacy of monoclonal antibodies, immune inhibitors and safety of cellular therapies.

Altis Biosystems has developed a stem cell platform that recreates the human intestinal epithelium, using proliferative stem cells and terminally differentiated cells. These cells are sourced from transplant-grade intestine. It is a high-throughput format, ideal for drug screening.

AlveoliX is a Swiss-based organ-on-chip company. Our product is comprised of different hardware components and the easy-to-handle organ-on-chip consumable AX12. On the AX12 healthy and diseased biomodels can be created to study drug safety and efficacy and to answer fundamental research questions.

AnaBios aims to establish the safety and efficacy of novel compounds through its advanced, human-focused translational technologies, including superior quality human tissue samples and functional assays focused, as well as human primary cells through its subsidiary Cell Systems.

Aracari’s vascularized micro-organ and tumor models incorporate perfused human vasculature for the physiologic delivery of nutrients, drugs and immune cells to multiple tissue and tumor types. These powerful next-generation tools are advancing discovery in immuno-oncology and drug development.

ATCC is a premier global biomaterials resource center and standards organization. We are accelerating scientific discoveries with our offerings of advanced 3D models, primary cells, iPSC-derived cells, and a wide range of other resources enabling MPS Technology.

Axol Bioscience are leaders in human iPSC products and services for CNS, PNS and cardiac research. Under ISO9001, we manufacture functional hiPSC-derived cells with multi-platform utility for MPS technology, alongside a “one-stop shop” of iPSC lines, services and custom assays.

AxoSim is a premier provider of neurological drug discovery platforms. The company’s proprietary BrainSim™ and NerveSim™ platforms provide accurate, predictive models of the peripheral and central nervous systems, delivering clinically-actionable human data early in the drug development process.

BiomimX develops the next generation of beating organs-on-chips. uBeat® Platforms and connected hardware provide 3D miniaturized constructs with a tunable mechanical stimulation to model human organs’ function and diseases. uBeat® products and customized drug screening services are available.

BrainXell is a CNS-focused supplier of iPSC-derived neurons, astrocytes, and microglia. Cells are made from control in-house lines and from customer-supplied disease lines. In addition, standardized and custom assays are available incorporating these cells.

CN Bio is a leading bioengineering company specializing in single and multi-organ microphysiological systems and innovative lab technologies. We aim to provide systems that generate clinically translatable data that can enhance the development of tomorrow’s medicines.

Curi’s suite of human iPSC-derived products and services enable scientists to build more mature and predictive human iPSC-derived tissues—with a focus on cardiac, musculoskeletal, and neuromuscular models—for the discovery, safety testing, and efficacy testing of new drugs in development.

Dynamic42 has developed a PDMS-free, easy-to-handle, affordable OoC platform. We specialize in vascular, liver, lung and intestinal biology and infection models. We further enable scientists with training courses to establish their own OoC models.

Emulate develops a breadth of Organ-Chip models with a focus on recreating the microenvironment and mechanical forces cells experience in vivo. Hardware automating media flow and stretch, Bio-Kits including chips and qualified human cells, and a range of standard and custom services are available.

Hesperos is accelerating drug discovery by providing safety and efficacy testing services using its Human-on-a-Chip, microphysiological system. This breakthrough technology enables unprecedented preclinical insight bringing better therapies to patients faster without the need for animal testing.

ImmuONE is a product provider of immune cell models and a specialized service provider for chemical safety assessment (e.g. e-cigarettes, cosmetics, therapeutics). We offer advanced in-vitro products and offer innovative in-house testing services using state-of-the-art equipment and techniques.

InSphero is the pioneer of industrial-grade, 3D-microtissue-based assay solutions and scaffold-free 3D organ-on-a-chip technology. The company specializes in liver toxicology, metabolic diseases (e.g., T1 & T2 diabetes and NAFLD & NASH liver disease), and immuno oncology.

KIYATEC’s clinically validated, predictive 3D ex vivo assays characterize response to I/O, targeted, and chemo therapies. Data from our proprietary platforms span most solid tumors including ovarian, GBM, breast, & rare. Our services cover all phases of preclinical development thru clinical trials.

Lena Biosciences offers Perfused Organ Panel MPS with a Blood Substitute hemoglobin analog that yields a log-fold increase in CYP450 activity in primary human hepatocytes to identify mitotoxic metabolites and DILI. Services focus on efficacy and toxicity in liver, brain, tumor, and blood models.

Advanced microfluidic technologies for Nanomedicine Development. We develop and employ human microphysiological systems or organ-on-a-chip to better predict drug toxicity and efficacy.

Mimetas develops high-throughput healthy and diseased organ-on-a-chip models in the OrganoPlate®, a screening-compatible microfluidics platform that supports the recreation of native tissue structures, and their interaction with compounds, signaling factors, disease triggers, and co-cultured cell types.

From our scientists and engineers to our service and support teams, we’re passionate about equipping researchers with next-generation technology that advances scientific discovery.

For more than a decade, Ncardia has been pioneering innovations in human induced pluripotent stem cells (iPSC).

NETRI is an industrial start-up developing innovative technologies for the pharmaceutical industry. Its patented organs-on-chip technologies allow the creation of standardized and predictive human in vitro models.

Providing next-generation HUMAN developmental neurotoxicity risk assessment to accelerate and reduce the cost of your chemical or drug discovery and development pipeline

Newcells Biotech uses 3D in vitro modelling expertise to develop nephrotoxicity and renal transporter assays that most accurately predict in vivo outcomes, as well as producing fully developed hiPSC-derived Retinal Organoids.

Provision of untouched intact tumor tissue platform to allow for the investigation of clinical relevant biomarkers, mechanism of action, safety and efficacy of therapeutics.

Obatala Sciences™ offers products and services for researchers working on diabetes, obesity, and cancer among other diseases. Obatala®’ products include the first human-derived hydrogel, ObaGel™, adipose-derived stem cells, and differentiation media, and the ObaCell Fat-on-a-Chip System™.

Ossiform provides scaffold-based bioceramic 3D cell culture systems that mimic the architecture and complexity of calcified bone tissue. The scaffolds are made from a nonpolymeric bioink consisting solely of β-TCP.

Qkine manufactures animal-free growth factors.
Our goal is to provide the highest purity proteins for research and bio-manufacturing to best support our customers and maximize the impact of their science.

We are the world-leading provider of reagents and services for generating organoid and stem cell-derived models of healthy and diseased human tissues.

Organ-on-Chip models from SynVivo recreate complex microvasculature including scale, morphology, hemodynamic shear stress, and cellular interactions in a perfused microfluidic chip environment. Validated models include Air Liquid Interface for Lung, Blood-Brain Barrier, Tumor, DIVI, Inflammation.

TissUse is a Berlin, Germany-based, biotechnology company who has developed a unique HUMIMIC Multi-Organ-Chip platform for advanced toxicity testing and cutting-edge disease modelling.

Through a series of technologies – Organ-on-Chip (OoC) and advanced magnetic resonance tools, Vitala delivers deep insights into metabolic kinetics at the cellular level

Our platform combines our unique Organ-on-a-Chip technology, multicellular 3D disease model development, and Artificial Intelligence (AI) to provide spatiotemporal profiling and analysis of drug testing and treatment at a cellular level.